Elite Pharmaceuticals, Inc. – Filings and Transcripts

OTC: ELTP
Share price (6/4/26): $0.40
Market cap (6/4/26): $431 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 Q3

ended 09/30/25 Q2

ended 06/30/25 Q1

ended 03/31/25 FY 2025

ended 12/31/24 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Shelf registration

Ownership Filter

Plassche Douglas

Plassche Douglas

Elite Pharmaceuticals, Inc.

Plassche Douglas

News Filter

Announces Filing of Abbreviated New Drug Application With the U.S. Food and Drug Administration for Generic Anticoagulant Product

Announces Commercial Launch of Methadone Hydrochloride Tablets

Reports Financial Results for the Third Quarter of Fiscal Year 2026 (Three Months Ended December 31, 2025) and Provides Conference Call Information

To Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026

Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information Conference Call Scheduled for Monday, November 17 at 11:30 AM EST

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC